DnB Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$464K Hold
1,229
– – ﹤0.01% 805
2026
Q2
$361K Hold
1,229
– – ﹤0.01% 937
2026
Q1
$343K Buy
+1,229
New +$354K ﹤0.01% 910
2025
Q2
– Sell
-3,661
Closed -$892K – 728
2025
Q1
$892K Buy
3,661
+221
+6% +$66.5K ﹤0.01% 633
2024
Q4
$1.13M Buy
3,440
+279
+9% +$94.7K ﹤0.01% 634
2024
Q3
$1.06M Sell
3,161
-258
-8% -$81.9K ﹤0.01% 629
2024
Q2
$934K Buy
3,419
+258
+8% +$75K ﹤0.01% 628
2024
Q1
$1.09M Buy
+3,161
New +$1.04M 0.01% 619

Other funds holding BIO

DnB Asset Management's BIO Position: Q3 2026 in Review

DnB Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 1,229 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #805.

DnB Asset Management first reported a position in BIO in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.13M in Q4 2024. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • DnB Asset Management held 1,229 shares of Bio-Rad Laboratories Class A worth $464K as of Q3 2026.
  • DnB Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of DnB Asset Management's portfolio in Q3 2026, its #805 holding.
  • DnB Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and has held it in 8 quarters since.
  • DnB Asset Management's Bio-Rad Laboratories Class A position peaked at $1.13M in Q4 2024.
  • 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on DnB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.